Searched for
DR SUSHIL SHAH
Padma Parade: From L Subramaniam to Ravichandran Ashwin & Osamu Suzuki, India honours trailblazers; check full listPresident Droupadi Murmu conferred the prestigious Padma Awards at Rashtrapati Bhavan, honoring 71 individuals for their exceptional contri...- I-Sec upgrades Metropolis Healthcare to Buy, lowers target price to Rs 2,250ICICI Securities has upgraded Metropolis Healthcare to Buy, setting a target price of Rs 2,250. The company reported a net profit of Rs 31....
- Add Metropolis Healthcare, target price Rs 2,335: ICICI SecuritiesICICI Securities maintains an Add rating on Metropolis Healthcare with a raised target price of Rs 2,335. Metropolis is acquiring Core Diag...
- Buy Metropolis Healthcare, target price Rs 1420: Sharekhan by BNP ParibasMetropolis Healthcare, incorporated in the year 2006, is a Mid Cap company (having a market cap of Rs 6849.87 Crore) operating in Hospitals...
- Buy Metropolis Healthcare, target price Rs 1775: JM FinancialMetropolis Healthcare, incorporated in the year 2006, is a Mid Cap company (having a market cap of Rs 6731.32 Crore) operating in Hospitals...
- Buy Metropolis Healthcare, target price Rs 1978: BNP Paribas SecuritiesPromoters held 49.79 per cent stake in the company as of 30-Jun-2022, while FIIs owned 23.2 per cent, DIIs 14.5 per cent.
- Phillip Capital maintains ‘buy’ on Indo Count, target price Rs 78The company has a strong product profile and customer relationships, which will help in current challenging times.
- Vote for Modi as he has made the country secure: Amit ShahAddressing five rallies in the state, Amit Shah said "here are the names of more than 100 welfare schemes launched by the Modi government.
- Metropolis Healthcare Rs 1,204 crore IPO to open on April 3The price band has been fixed in the range of Rs 877-880 per share.
- Metropolis eyes SRL in spinoff dealMetropolis was exploring a consolidation deal which could make it the largest diagnostics chain in Asia’s third-largest economy, sources sa...
- Global investment summit will be game changer for Assam: Ravi CapoorBJP led Assam government has stated the summit which will be inaugurated by Prime minister, Narendra Modi on February 3 will attended 20 in...
- Ratan Tata, Mukesh Ambani to participate in Guwahati global investors' summit, claims Assam ministerThe first ever global investment summit will be held in Guwahati on February 3-4. The event will be inaugurated by Prime minister Narendra ...
- Entrepreneur Velu back in diagnosticsThe re-entry puts him in direct competition with his former partner, Ameera Shah.
- Buy Indo Count Industries, target Rs 136: Kunal BothraBuy Indo Count Industries at a price target of Rs 136 and a stop loss at Rs 108 from entry point.
- Sell Indo Count Industries, target Rs 91: Manas JaiswalSell Indo Count Industries at a price target of Rs 91 and a stop loss at Rs 103 from entry point.
- Buy Heidelberg Cement India, target Rs 151: Dharmesh ShahBuy Heidelberg Cement India Ltd. at a price target of Rs 151.0 and a stop loss at Rs 129.0 from entry point
- An equal music: How Ashni Biyani & Lara Balsara overcame gender bias in the boardroomThe boardroom can be a tough place for women, even for those with famous dads.
- Carlyle may end Metropolis feud with Rs 900 crore stake buyMetropolis s today a multinational chain with more than 125 laboratories, tracking Rs 600-crore revenue annually.
- Metropolis boardroom becomes a battleground: Warburg Pincus’ stake sale to Shahs irks partner VeluDr GSK Velu has reacted angrily to last week’s transaction between Warburg and the Shah family, which resulted in the Shahs increasing thei...
- Top PEs including Apax Partners & Temasek eye a deal in Metropolis HealthcareThe dealmaking in Metropolis coincides with IPO plans of other players, notably Dr Lal Pathlabs, SRL and Thyrocare, all of whom could list ...
Load More
